ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 171 filers reported holding ANIKA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $847,348 | -53.9% | 45,483 | -35.7% | 0.00% | -60.0% |
| Q2 2023 | $1,836,344 | -13.0% | 70,683 | -3.8% | 0.01% | 0.0% |
| Q1 2023 | $2,110,432 | -17.4% | 73,483 | -14.8% | 0.01% | -28.6% |
| Q4 2022 | $2,553,977 | +54.9% | 86,283 | +24.5% | 0.01% | +40.0% |
| Q3 2022 | $1,649,000 | -13.0% | 69,283 | -18.4% | 0.01% | 0.0% |
| Q2 2022 | $1,895,000 | +9.9% | 84,883 | +23.6% | 0.01% | 0.0% |
| Q1 2022 | $1,725,000 | -19.2% | 68,683 | +15.3% | 0.01% | 0.0% |
| Q4 2021 | $2,135,000 | -21.4% | 59,583 | -6.6% | 0.01% | -28.6% |
| Q3 2021 | $2,715,000 | -41.8% | 63,783 | -40.8% | 0.01% | -41.7% |
| Q2 2021 | $4,666,000 | +7.1% | 107,783 | +0.9% | 0.01% | 0.0% |
| Q1 2021 | $4,356,000 | +16.3% | 106,783 | +29.0% | 0.01% | +20.0% |
| Q4 2020 | $3,747,000 | +19.4% | 82,783 | -6.7% | 0.01% | +11.1% |
| Q3 2020 | $3,138,000 | -9.8% | 88,683 | -3.8% | 0.01% | -10.0% |
| Q2 2020 | $3,478,000 | +31.1% | 92,193 | +0.5% | 0.01% | 0.0% |
| Q1 2020 | $2,652,000 | -55.8% | 91,719 | -20.7% | 0.01% | -28.6% |
| Q4 2019 | $5,995,000 | -31.3% | 115,619 | -27.3% | 0.01% | -33.3% |
| Q3 2019 | $8,729,000 | +6.2% | 159,019 | -21.4% | 0.02% | +5.0% |
| Q2 2019 | $8,222,000 | +25.2% | 202,419 | -6.8% | 0.02% | +17.6% |
| Q1 2019 | $6,566,000 | +55.8% | 217,119 | +73.1% | 0.02% | +41.7% |
| Q4 2018 | $4,215,000 | -22.5% | 125,419 | -2.8% | 0.01% | -7.7% |
| Q3 2018 | $5,442,000 | +18.5% | 129,019 | -10.1% | 0.01% | +8.3% |
| Q2 2018 | $4,593,000 | +41.8% | 143,519 | +120.4% | 0.01% | +33.3% |
| Q1 2018 | $3,238,000 | -8.3% | 65,119 | -0.6% | 0.01% | -10.0% |
| Q4 2017 | $3,532,000 | -24.9% | 65,519 | -19.2% | 0.01% | -23.1% |
| Q3 2017 | $4,705,000 | +4.0% | 81,119 | -11.6% | 0.01% | -13.3% |
| Q2 2017 | $4,525,000 | +45.6% | 91,719 | +28.2% | 0.02% | +50.0% |
| Q1 2017 | $3,107,000 | -4.0% | 71,519 | +8.2% | 0.01% | -16.7% |
| Q4 2016 | $3,237,000 | +0.8% | 66,111 | -1.4% | 0.01% | -14.3% |
| Q3 2016 | $3,210,000 | -32.0% | 67,082 | -23.8% | 0.01% | -41.7% |
| Q2 2016 | $4,720,000 | +14.3% | 87,983 | -4.8% | 0.02% | +4.3% |
| Q1 2016 | $4,131,000 | +42.1% | 92,383 | +21.3% | 0.02% | +35.3% |
| Q4 2015 | $2,907,000 | +103.0% | 76,183 | +70.1% | 0.02% | +88.9% |
| Q3 2015 | $1,432,000 | +304.5% | 44,783 | +415.8% | 0.01% | +200.0% |
| Q4 2014 | $354,000 | -66.7% | 8,683 | -70.0% | 0.00% | -62.5% |
| Q3 2014 | $1,063,000 | -60.0% | 28,983 | -49.5% | 0.01% | -61.9% |
| Q2 2014 | $2,659,000 | +20.7% | 57,383 | +7.1% | 0.02% | +5.0% |
| Q1 2014 | $2,203,000 | -9.9% | 53,583 | -16.4% | 0.02% | -16.7% |
| Q4 2013 | $2,446,000 | +46.3% | 64,083 | -8.2% | 0.02% | +20.0% |
| Q3 2013 | $1,672,000 | +140.2% | 69,783 | +70.7% | 0.02% | +100.0% |
| Q2 2013 | $696,000 | – | 40,883 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caligan Partners LP | 1,081,360 | $20,145,737 | 9.25% |
| Trigran Investments, Inc. | 2,217,019 | $41,303,065 | 4.40% |
| DIKER MANAGEMENT LLC | 50,239 | $935,953 | 0.84% |
| Virtus Investment Advisers, Inc. | 45,579 | $849,137 | 0.58% |
| Virtus Fund Advisers, LLC | 3,490 | $65,019 | 0.46% |
| CAPITAL MANAGEMENT CORP /VA | 84,225 | $1,569,112 | 0.35% |
| Riverwater Partners LLC | 17,597 | $327,832 | 0.30% |
| BOOTHBAY FUND MANAGEMENT, LLC | 617,602 | $11,505,925 | 0.27% |
| XTX Topco Ltd | 28,033 | $522,255 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 51,638 | $962 | 0.08% |